Verdad Advisers »

Nurix Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 83k 15.50

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Vestal Point Capital
Deep Track Capital
Vanguard Group
FMR
State Street Corporation
Morgan Stanley
Baker Bros. Advisors
Vanguard Capital Management
General Atlantic
Perceptive Advisors
Pictet Asset Management Holding SA
Geode Capital Management
Rubric Capital Management

View all funds holding Nurix Therapeutics